Gross domestic product rebounded in the spring after contracting at the start of the year, but consumer spending remained weak.
Category: United States Politics and Government
-
What to Watch at the Federal Reserve’s July Meeting
The U.S. central bank is widely expected to hold interest rates steady for a fifth straight meeting despite badgering from President Trump to lower borrowing costs.
-
What to Watch at the Federal Reserve’s July Meeting
The U.S. central bank is widely expected to hold interest rates steady for a fifth straight meeting despite badgering from President Trump to lower borrowing costs.
-
Trump Urges the U.K. to Drill More Oil, Criticizing Its Energy Policy
President Trump said the North Sea was a “treasure chest,” but its high taxes were driving away oil producers.
-
Boeing Reports Strongest Revenue in Six Years
Although the aerospace company lost money in the second quarter, it built and sold more planes as it recovered from quality crises and a workers strike.
-
I.M.F. Raises Global Growth Outlook as U.S. Looks to Avert Trade Wars
The International Monetary Fund warned that trade tension continued to be a risk for the global economy.
-
Are Cracks Appearing in Trump’s Antitrust Strategy?
Two top officials are reportedly out of a job, amid reported disagreements within the Justice Department over how it regulates deals.
-
Powell Under Siege as Fed Plans to Stand Pat on Rate Cuts
Jerome H. Powell, the Federal Reserve chair, is facing relentless attacks from the president, a lively campaign to replace him and divisions in his own ranks over when to cut interest rates.
-
When Coke and Pepsi Fought for Soft Drink Supremacy in Space
In the summer of 1985, NASA, the Reagan White House and seven talented astronauts got wrangled into an orbital chapter of the cola wars.
-
Study Undercuts Idea That Cash Payments to Poor Families Help Child Development
Rigorous new research appears to show that monthly checks intended to help disadvantaged children did little for their well-being, adding a new element to a dispute over expanded government aid.
-
Tariffs on Medicines From Europe Stand to Cost Drugmakers Billions
Many pharmaceutical products made in Europe will face a 15 percent tariff, pinching manufacturers and potentially leading to higher drug prices.